-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SQqtXm9fD422JgQ/zfoq0wsj0uyM3PGy1OyBRmdUIm3A9YKJpk1a03rWpx5dvszD sbftr5LJqLDROlrsQQJz7A== 0000889812-98-002539.txt : 19981030 0000889812-98-002539.hdr.sgml : 19981030 ACCESSION NUMBER: 0000889812-98-002539 CONFORMED SUBMISSION TYPE: 10-K405/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980630 FILED AS OF DATE: 19981029 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMBI INC CENTRAL INDEX KEY: 0000744962 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 112653613 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K405/A SEC ACT: SEC FILE NUMBER: 001-12106 FILM NUMBER: 98732764 BUSINESS ADDRESS: STREET 1: 4 MANHATTANVILLE ROAD CITY: PURCHASE STATE: NY ZIP: 10577-2197 BUSINESS PHONE: 9147014500 MAIL ADDRESS: STREET 1: 4 MANHATTANVILLE ROAD CITY: PURCHASE STATE: NY ZIP: 10577-2197 FORMER COMPANY: FORMER CONFORMED NAME: APPLIED MICROBIOLOGY INC DATE OF NAME CHANGE: 19920703 10-K405/A 1 AMENDED ANNUAL REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Fiscal Year ended June 30, 1998 Commission File Number 0-14983 AMBI INC. ------------------------------------------------------ (Exact Name of Registrant as Specified in its Charter) New York 11-2653613 - --------------------------------------------- ---------------------- (State or other jurisdiction of incorporation (I.R.S. Employer or organization) Identification Number) 4 Manhattanville Road Purchase, New York 10577-2197 - ---------------------------------------- ---------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including Area Code: (914) 701-4500 ---------------------- Securities registered pursuant to Section 12(b) of the Act: Common Stock (par value $.005 per share) ---------------------------------------- Securities registered pursuant to Section 12(g) of the Act: Common Stock (par value $.005 per share) ---------------------------------------- Title of Class Redeemable Warrants ------------------- Title of Class Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past ninety (90) days. Yes X No ----- ----- Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the registrant's best knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X] The aggregate market value of voting stock held by non-affiliates of the Registrant was approximately $9,735,000 as of October 8, 1998. The number of shares outstanding of Registrant's Common Stock as of October 8, 1998: 25,468,145. ITEM 6. SELECTED FINANCIAL DATA The following table summarizes selected consolidated financial data that are qualified by the more detailed financial statements included herein. Figures are stated in thousands of dollars, except per share amounts.
YEAR ENDED JUNE 30 1998(2) 1997(1) 1996 1995 1994 - --------------------------------------------------------------------------------------------------------------------- Sales $20,758 $11,280 $16,022 $11,726 $10,156 Gross Profit 17,802 6,282 9,669 8,468 6,630 Operating Income/(Loss) 1,467 (16,635) (4,621) 440 1,815 Income/(Loss) before taxes(3) 1,168 (6,661) (4,434) 537 1,941 Tax Expense 116 152 285 254 185 Net Income/(Loss) 1,052 (6,813) (4,719) 283 1,756 Diluted Earnings /(Loss) per Share (0.04) (0.38) (0.34) 0.01 0.09 SELECTED BALANCE SHEET DATA: 1998 1997(1) 1996 1995 1994 - --------------------------------------------------------------------------------------------------------------------- Working Capital $(2,269) $7,055 $14,812 $7,333 $7,352 Total Assets 20,735 12,754 23,367 13,788 11,808 Total Liabilities 10,437 5,144 6,221 3,163 1,544 Long Term Obligations and Redeemable Preferred Stock 1,543 2,184 4,408 2,267 1,500 Stockholders' Equity $10,298 $7,610 $15,646 $9,125 $8,764
(1) The results for the year ended June 30, 1997, are those of the Company and Aplin & Barrett for the period July 1, 1996 through December 11, 1996 and those of the Company only for the full year (see Item 13-Certain Relationships and Related Transactions). (2) Consolidated Statement of Operations includes the operations of Nutrition 21 from August 11, 1997, the date of acquisition. (3) Includes gain of $9.7 million on sale of Aplin & Barrett in fiscal 1997. The Company has not paid a cash dividend to its public shareholders on its Common Stock. The Company intends to retain all earnings for the foreseeable future for use in the operation and expansion of its business and, accordingly, the Company does not contemplate paying any cash dividends on its Common Stock in the near future. SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. AMBI INC. By: /s/ Fredric D. Price ---------------------------- Fredric D. Price, President, CEO and Director Dated: October 29, 1998 Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below as of October 29, 1998 by the following persons on behalf of Registrant and in the capacities indicated. /s/ Fredric D. Price ---------------------------- Fredric D. Price, President, CEO and Director /s/ Robert E. Flynn ---------------------------- Robert Flynn, Chairman of the Board /s/ P. George Benson ---------------------------- P. George Benson, Director /s/ Audrey T Cross ---------------------------- Audrey T. Cross, Director /s/ Marvin Moser ---------------------------- Marvin Moser, Director /s/ Robert E. Pollack ---------------------------- Robert E. Pollack, Director /s/ Gerald A. Shapiro ---------------------------- Gerald A. Shapiro, Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----